Flush with AZ cash, Almirall seeks dermatology assets

 
• By Eleanor Malone

Almirall has fresh funds and wants to spend them on acquiring new dermatology assets, CEO Eduardo Sanchiz said following the surprise announcement that the Spanish firm is to sell its respiratory portfolio to AstraZeneca.

More from Respiratory

More from Therapy Areas